Browsing by Author "Volckmar, AL"
Now showing 1 - 3 of 3
- Results Per Page
- Sort Options
- Some of the metrics are blocked by yourconsent settingsA framework for risk stratification in EGFR+ lung adenocarcinoma treated with tyrosine kinase inhibitors(2019)
;Christopoulos, P ;Kirchner, M ;Bozorgmehr, F ;Magios, N ;Volckmar, AL ;Endris, V ;Penzel, R ;Heußel, CP ;Winter, H; ;Muley, T ;Meister, M ;Lasitschka, F ;Bischoff, HG ;Schirmacher, P ;Stenzinger, AThomas, M - Some of the metrics are blocked by yourconsent settingsClinical and molecular profile of de novo vs. secondary EGFR mutated metastatic non-small-cell lung cancer(2020)
;Christopoulos, P ;Bozorgmehr, F ;Volckmar, AL ;Kirchner, M ;Magios, N ;Kuon, J ;Kazdal, D ;Budczies, J ;Endris, V ;Bochtler, T ;Herth, FJF ;Heussel, CP ;Winter, H ;Muley, T ;Meister, M; ;Faehling, M ;Bischoff, H ;Stenzinger, AThomas, M - Some of the metrics are blocked by yourconsent settingsTP53 status conversion defines an unfavourable patient subset with inferior overall survival in ALK+ lung adenocarcinoma(2019)
;Christopoulos, P ;Dietz, S ;Kirchner, M ;Volckmar, AL ;Endris, V ;Elsayed, M ;Ogrodnik, SJ ;Heußel, CP; ;Muley, T ;Meister, M ;Lasitschka, F ;Zemojtel, T ;Bischoff, HG ;Schirmacher, P ;Sültmann, H ;Stenzinger, AThomas, M